首页> 外文期刊>Toxicologic pathology >Regulatory Forum Opinion Piece*: An Experienced Pathologist Need Not Always Be Present at Necropsy for Small Molecule or Biotherapeutic Safety Studies
【24h】

Regulatory Forum Opinion Piece*: An Experienced Pathologist Need Not Always Be Present at Necropsy for Small Molecule or Biotherapeutic Safety Studies

机译:监管论坛意见书*:对于小分子或生物治疗安全性研究,尸检不一定需要有经验的病理学家

获取原文
获取原文并翻译 | 示例
           

摘要

It is the author's opinion that an experienced pathologist need not always be present at necropsy for safety studies to support development of large or small molecules. Reasons why an experienced pathologist need not be present in the room for every study as well as the value of necropsy attendance as a training opportunity for less experienced pathologists are presented. However, there are studies for which an experienced pathologist should be in attendance at necropsy and examples of these types of studies are listed.
机译:作者认为,经验丰富的病理学家不一定需要在尸检时进行安全性研究以支持大分子或小分子的发育。提出了为什么不需要有经验的病理学家参加每个研究室的原因以及尸检作为没有经验的病理学家的培训机会的价值。但是,有些研究需要经验丰富的病理学家参加尸检,并列出了这类研究的例子。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号